Terms: = Lung cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
1033 results:
1. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma.
Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q
BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064
[TBL] [Abstract] [Full Text] [Related]
2. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
Dang J; Xu G; Guo G; Zhang H; Shang L
J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of Prognostic Features Based on Neutrophil-Related Genes for lung Squamous Cell Carcinoma Reveals Immune Landscape and Drug Candidates.
Sili D; Nan Z
Rev Invest Clin; 2024; 76(2):116-131. PubMed ID: 38740381
[TBL] [Abstract] [Full Text] [Related]
5. Gefitinib metabolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma.
Guo Z; Zhang X; Yang D; Hu Z; Wu J; Zhou W; Wu S; Zhang W
Sci Rep; 2024 May; 14(1):10348. PubMed ID: 38710798
[TBL] [Abstract] [Full Text] [Related]
6. Significance of
Lin H; Wang J; Shi Q; Wu M
PeerJ; 2024; 12():e17338. PubMed ID: 38708353
[TBL] [Abstract] [Full Text] [Related]
7. Identifying lncRNAs and mRNAs related to survival of NSCLC based on bioinformatic analysis and machine learning.
Yue W; Wang J; Lin B; Fu Y
Aging (Albany NY); 2024 May; 16(9):7799-7817. PubMed ID: 38696317
[TBL] [Abstract] [Full Text] [Related]
8. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma].
Mei W; Wang XM; Liu RA; Xiong W; Zhang YP
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988
[No Abstract] [Full Text] [Related]
9. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in lung Adenocarcinoma and Squamous Cell Carcinoma.
Koh YW; Han JH; Haam S; Lee HW
Anticancer Res; 2024 May; 44(5):2081-2089. PubMed ID: 38677736
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of large amino acid transporter type 1 (LAT1) expression in pulmonary adenocarcinoma: A tissue microarray study.
Terao A; Ninomiya H; Takeuchi K
Cancer Treat Res Commun; 2024; 39():100814. PubMed ID: 38677033
[TBL] [Abstract] [Full Text] [Related]
11. Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer.
Zheng L; Hu F; Huang L; Lu J; Yang X; Xu J; Wang S; Shen Y; Zhong R; Chu T; Zhang W; Li Y; Zheng X; Han B; Zhong H; Nie W; Zhang X
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38641349
[TBL] [Abstract] [Full Text] [Related]
12. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
Miao L; Wu D; Zhao H; Xie A
Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
[TBL] [Abstract] [Full Text] [Related]
13. Architecting the metabolic reprogramming survival risk framework in LUAD through single-cell landscape analysis: three-stage ensemble learning with genetic algorithm optimization.
Sun X; Nong M; Meng F; Sun X; Jiang L; Li Z; Zhang P
J Transl Med; 2024 Apr; 22(1):353. PubMed ID: 38622716
[TBL] [Abstract] [Full Text] [Related]
14. Predictors of cancer-specific survival and overall survival among patients aged ≥60 years with lung adenocarcinoma using the SEER database.
Li F; Li F; Zhao D; Lu H
J Int Med Res; 2024 Apr; 52(4):3000605241240993. PubMed ID: 38606733
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
Wu X; Zhao X; Zhou C; Wei N; Xu Z; Zhang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):188. PubMed ID: 38602568
[TBL] [Abstract] [Full Text] [Related]
16. Construction of a prognostic model based on memory CD4+ T cell-associated genes for lung adenocarcinoma and its applications in immunotherapy.
Li Y; Ye X; Huang H; Cao R; Huang F; Chen L
CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):837-852. PubMed ID: 38594917
[TBL] [Abstract] [Full Text] [Related]
17. Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms.
Xie J; Wu D; Zhang P; Zhao S; Qi M
Exp Dermatol; 2024 Apr; 33(4):e15070. PubMed ID: 38570935
[TBL] [Abstract] [Full Text] [Related]
18. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
[TBL] [Abstract] [Full Text] [Related]
19. Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment.
Zhao X; Zhao R; Wen J; Zhang X; Wu S; Fang J; Ma J; Gao L; Hu Y
Med Oncol; 2024 Mar; 41(5):96. PubMed ID: 38526604
[TBL] [Abstract] [Full Text] [Related]
20. Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.
Zhang Y; Xiao L; LYu L; Zhang L
PeerJ; 2024; 12():e17098. PubMed ID: 38495760
[TBL] [Abstract] [Full Text] [Related]
[Next]
